Tenaya Therapeutics Inc
TNYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$149.75M
Close$
$0.59
15.6% downside
Current Fair Value
15.6% downsideOvervalued by 15.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $149.75 Million |
|---|---|
| Enterprise Value | $81.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.59 |
| Beta | 2.79 |
| Outstanding Shares | 217,574,637 |
Return
| Return on Equity | -148.56% |
|---|---|
| Return on Assets | -110.24% |
| Return on Invested Capital | -142.20% |
Valuation & Multiples
| P/E Ratio | -1.3 |
|---|---|
| PEG | -1.51 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 60.93 |
| Enterprise Value to EBIT | -0.77 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$10.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$802,500
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2492▼ 4.13% |
|---|---|
| Total Calls | 275,700▼ 14.25% |
| Total Puts | 68,700▼ 26.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.04%▼ 19.81% |
|---|---|
| Total Invested | $37.51M▼ 23.15% |
| Investors Holding | 108▲ 3.00% |
ESG Score
No data
About Tenaya Therapeutics Inc
2,021 employees